NCT04018677

Brief Summary

The goal of this project is to iteratively develop and test a TOGETHER pilot mobile app product in preparation for commercialization. TOGETHER is a mobile application on a smart software system that informal caregivers can use to develop and implement home-based care for cancer patients/survivors. The Technical Objectives are to:

  1. 1.Establish the project team and obtain stakeholder feedback on what to include in the product.
  2. 2.Evaluate IT customization requirements and HIPAA compliance security, and privacy protocols.
  3. 3.Develop a prototype to show NCI and then a pilot version for beta and usability testing among stakeholders.
  4. 4.Enhance interoperability and test integration into health system(s) - if feasible.
  5. 5.Develop user support documentation for stakeholders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable cancer

Timeline
Completed

Started May 2019

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 7, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 18, 2019

Completed
24 days until next milestone

First Posted

Study publicly available on registry

July 12, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2021

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2022

Completed
Last Updated

August 24, 2023

Status Verified

August 1, 2023

Enrollment Period

2.2 years

First QC Date

June 18, 2019

Last Update Submit

August 22, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Assess user experience with TOGETHER app

    User experiences will be assessed by measuring overall experiences.

    1 year

  • Assess user experience with TOGETHER app

    User experiences will be assessed by measuring module recommendation.

    1 year

  • Assess user experience with TOGETHER app

    User experiences will be assessed by measuring dynamics/flow of app use, module recommendation, and general demographics.

    1 year

  • Assess user experience with TOGETHER app

    User experiences will be assessed by measuring problems with app use.

    1 year

  • Assess caregiver's experience with TOGETHER app

    Caregiver's experience with TOGETHER app will be assessed for clarity of documentation.

    1 year

  • User documentation feedback

    General feedback/recommendations for the app, including user documentation feedback.

    1 year

Study Arms (2)

Beta Testing

EXPERIMENTAL

For the beta testing, input will be provided by cancer patient/survivor, caregivers, and clinicians. TOGETHER app will be downloaded on smart phone. Subjects will be asked to answer questions and/or perform activities on his/her smartphone device. Project information will include responses to surveys and giving additional feedback on app user experience.

Behavioral: Use of TOGETHERCare app

Usability testing

EXPERIMENTAL

For the usability testing, caregivers will be the primary type of stakeholder providing input. TOGETHER app will be downloaded on smart phone. Subjects will be asked to answer questions and/or perform activities on his/her smartphone device. Project information will include responses to surveys and giving additional feedback on app user experience.

Behavioral: Use of TOGETHERCare app

Interventions

TOGETHERCare (Medable Inc.) is a mobile software application on a smart software system that informal caregivers can use to develop and implement home-based care for cancer patients/survivors. It is intended to improve the care experience by helping to alleviate the cancer care-giving burden and facilitate communication with patients' healthcare teams by centering the conversation around a care plan.

Beta TestingUsability testing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (aged 18 years or older) who are either:
  • Cancer patient/survivor receiving care or with plans to transition to care in the community setting.
  • Caregiver of cancer patient/survivor receiving care or with plans to transition to care in the community setting.
  • Clinician of cancer patient/survivor receiving care or with plans to transition to care in the community setting.
  • Cancer patient is a patient of Stanford Health Care.
  • Patient, Caregiver, and Clinician are willing to be connected on the app.
  • Have a smartphone and data plan that allows for app installation and usage.
  • Must speak, read and write in English, because all study materials and communication will be in English.

You may not qualify if:

  • Patient does not have a cancer diagnosis.
  • Cancer patient/survivor is not receiving care or does not have plans to transition to care in the community setting.
  • Cancer patient is not a patient of Stanford Health Care.
  • Patient, Caregiver, and Clinician are not willing to be connected on the app.
  • Unable to speak, read and write in English.
  • Does not have a smartphone nor data plan that allows for app installation and usage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Stanford, California, 94304, United States

Location

Related Publications (1)

  • Oakley-Girvan I, Davis SW, Kurian A, Rosas LG, Daniels J, Palesh OG, Mesia RJ, Kamal AH, Longmire M, Divi V. Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study. JMIR Form Res. 2021 Aug 13;5(8):e22608. doi: 10.2196/22608.

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Vasu Divi, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2019

First Posted

July 12, 2019

Study Start

May 7, 2019

Primary Completion

July 21, 2021

Study Completion

June 25, 2022

Last Updated

August 24, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations